Home > Drug Search >
  • company_query: Altimmune
  •   > 
Drug Filter
Category:
chemistry (4) biology (31)
Status:
Approved (3) Phase Ⅲ (6) Phase Ⅱ (12) Phase Ⅰ (13) IND Filing (1)
Clinical Stage:
Pending (2) Active (27) Discontinued (3)
Bio-Type:
Gene therapy (2) Vaccine (23) Recombinant cytokines (3) Whole antibody (2) Fusion protein (1)
Indication:
Meningitis (3) Acute myeloid Leukemia (AML) (1) Breast cancer (2) Uveal melanoma (1) Wet age-related macular degeneration (1) Cytomegalovirus infections (1) HBV infection (1) HIV infection (2) Lung cancer (1) Major depressive disorder (MDD) (1) Melanoma (1) Multiple sclerosis (MS) (2) Non small cell lung cancer (NSCLC) (1) Obesity (1) Ovarian cancer (1) Pneumonia (1) Haemophilus infection (1) Prostate cancer (3) Poliomyelitis (1) Renal cell carcinoma (1) Solid tumours (3) Systemic lupus erythematosus (1) Tuberculosis (1) Influenza A virus infections (3) Colorectal cancer (2) Diagnostic agents (1) Malaria (2) Neutropenia (1) Renal carcinoma (2) Glioblastoma (2) Glioma (1) Mesothelioma (1) Brain cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top